Home › Funds › Game Creek Capital, LP › REGN

Game Creek Capital, LP position in REGN

REGENERON PHARMACEUTICALS · Health Care

Game Creek Capital, LP reported holding 1,710 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.60% of its reported portfolio and ranking #45 among its reported holdings. Game Creek Capital, LP has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.71K sh
Reported value held$1.30M
Portfolio Weight0.60%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Game Creek Capital, LP's REGN position evolved

Game Creek Capital, LP first disclosed a stake in REGN in Q2 2025 at 3,075 shares (US$1.6M). The position peaked in Q4 2025 at 8,435 shares, worth US$6.5M. Across 6 filings, Game Creek Capital, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,710 shares valued at US$1.3M — an increase of 1,210 shares quarter over quarter.. Notable position changes include a 71% increase in Q4 2025 (shares were roughly flat over the following quarter), a 88% trim in Q1 2026 (shares fell 18% over the following quarter), a 242% increase in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 3.08K $1.61M New
Q3 2025 4.92K $2.77M Add
Q4 2025 8.44K $6.51M Add
Q1 2026 1.00K $772.64K Reduce
Q2 2026 500 $311.77K Reduce
Q3 2026 1.71K $1.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Game Creek Capital, LP held REGN?

Game Creek Capital, LP has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Game Creek Capital, LP's current position in REGN?

As of Q3 2026, Game Creek Capital, LP holds 1.71K shares of REGN (REGENERON PHARMACEUTICALS), valued at $1.30M, representing 0.60% of its reported portfolio and ranking #45.

Has Game Creek Capital, LP been buying or selling REGN?

In the latest 13F filing (Q3 2026), Game Creek Capital, LP increased its position in REGN. The position peaked in Q4 2025 at 8.44K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.